Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China · Delayed Price · Currency is CNY 6.88
-0.13 (-1.85%)
Nov 13, 2026, 3:00 PM CST
SHA:600789 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,409 | 2,344 | 772.54 | 798.46 | 688.81 | 576.85 |
Trading Asset Securities | - | - | 1.22 | 1.19 | 1.26 | 1.21 |
Cash & Short-Term Investments | 1,409 | 2,344 | 773.76 | 799.65 | 690.07 | 578.06 |
Cash Growth | 79.17% | 202.98% | -3.24% | 15.88% | 19.38% | -10.90% |
Accounts Receivable | 1,304 | 1,016 | 1,437 | 1,346 | 1,232 | 824.41 |
Other Receivables | 271.63 | 264.82 | 354.78 | 14.97 | 18.42 | 31.36 |
Receivables | 1,575 | 1,280 | 1,792 | 1,361 | 1,251 | 855.76 |
Inventory | 1,445 | 1,247 | 1,484 | 1,406 | 1,481 | 1,208 |
Prepaid Expenses | - | 4.23 | 3.98 | 2.82 | 1.29 | - |
Other Current Assets | 148.07 | 74.43 | 76.54 | 78.32 | 86.17 | 109.49 |
Total Current Assets | 4,577 | 4,951 | 4,130 | 3,648 | 3,509 | 2,751 |
Property, Plant & Equipment | 3,847 | 3,900 | 3,833 | 3,887 | 4,047 | 3,921 |
Long-Term Investments | 72.06 | 80.27 | 88 | 103.13 | 89.84 | 69.67 |
Other Intangible Assets | 841.39 | 786.79 | 766.2 | 724.04 | 603.01 | 570.13 |
Long-Term Deferred Tax Assets | 42.06 | 40.52 | 24.03 | 31.02 | 25.98 | 21.66 |
Long-Term Deferred Charges | 100.97 | 125.38 | 128.4 | 107.79 | 148.58 | 170.17 |
Other Long-Term Assets | 157.71 | 150.19 | 128.52 | 301.58 | 304.76 | 318.47 |
Total Assets | 9,639 | 10,034 | 9,098 | 8,802 | 8,728 | 7,822 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,584 | 1,048 | 1,503 | 1,503 | 1,611 | 1,164 |
Accrued Expenses | 19.24 | 48.42 | 35.37 | 140.38 | 145.08 | 104.27 |
Short-Term Debt | 396.48 | 1,108 | 871.77 | 1,102 | 1,344 | 1,282 |
Current Portion of Long-Term Debt | 325.87 | 872.3 | 282.56 | 464.63 | 640.6 | 673.07 |
Current Portion of Leases | - | - | - | - | 1.57 | 0.88 |
Current Income Taxes Payable | 42.94 | 23.79 | 1.97 | 5.9 | 4.67 | 5.46 |
Current Unearned Revenue | 105.48 | 82.86 | 104.66 | 209.08 | 216.6 | 129.49 |
Other Current Liabilities | 188.32 | 214.98 | 261.92 | 92.2 | 165.3 | 118.36 |
Total Current Liabilities | 2,662 | 3,398 | 3,061 | 3,517 | 4,129 | 3,478 |
Long-Term Debt | 1,326 | 1,089 | 1,686 | 1,309 | 867.18 | 692.4 |
Long-Term Leases | - | - | - | - | - | 0.62 |
Long-Term Unearned Revenue | 273.52 | 288.03 | 165.72 | 110.97 | 100.41 | 99.04 |
Other Long-Term Liabilities | 2 | 2 | 123.86 | 123.86 | 123.86 | 123.86 |
Total Liabilities | 4,263 | 4,777 | 5,036 | 5,061 | 5,220 | 4,394 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,045 | 1,045 | 898.67 | 896.04 | 886.88 | 880.6 |
Additional Paid-In Capital | 2,738 | 2,738 | 1,698 | 1,683 | 1,630 | 1,653 |
Retained Earnings | 1,467 | 1,354 | 1,342 | 1,047 | 849.26 | 755.36 |
Comprehensive Income & Other | -25.76 | -23.06 | -21.06 | -14.29 | -9.59 | -5.58 |
Total Common Equity | 5,225 | 5,115 | 3,918 | 3,612 | 3,357 | 3,283 |
Minority Interest | 150.5 | 141.98 | 143.39 | 129.65 | 150.31 | 145.17 |
Shareholders' Equity | 5,375 | 5,257 | 4,062 | 3,741 | 3,507 | 3,428 |
Total Liabilities & Equity | 9,639 | 10,034 | 9,098 | 8,802 | 8,728 | 7,822 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,048 | 3,069 | 2,840 | 2,876 | 2,854 | 2,649 |
Net Cash (Debt) | -639 | -725.14 | -2,066 | -2,076 | -2,164 | -2,071 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.61 | -0.77 | -2.30 | -2.36 | -2.35 | -2.32 |
Filing Date Shares Outstanding | 971.93 | 1,045 | 898.67 | 896.04 | 886.88 | 880.6 |
Total Common Shares Outstanding | 971.93 | 1,045 | 898.67 | 896.04 | 886.88 | 880.6 |
Working Capital | 1,915 | 1,553 | 1,069 | 130.46 | -620.23 | -727.25 |
Book Value Per Share | 5.38 | 4.89 | 4.36 | 4.03 | 3.79 | 3.73 |
Tangible Book Value | 4,384 | 4,328 | 3,152 | 2,888 | 2,754 | 2,713 |
Tangible Book Value Per Share | 4.51 | 4.14 | 3.51 | 3.22 | 3.11 | 3.08 |
Buildings | - | 2,258 | 2,222 | 2,100 | 1,975 | 1,802 |
Machinery | - | 4,071 | 3,803 | 3,629 | 3,503 | 3,054 |
Construction In Progress | - | 239.75 | 121.86 | 100.97 | 175.53 | 359.25 |